Panel Discussion: Practical and Hot Topics

Monday, February 27, 2023

5:20 PM – 5:45 PM ET

Panel Moderator(s)

Howard C. Herrmann, MD, FACC, MSCAI

Director, Interventional Cardiology and Cardiac Cath Labs
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States

Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Highlife Medical: Contracted Research (Ongoing); Holistick Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Innovalve: Grant/Research Support (Ongoing); medtronic: Consultant (Ongoing); Microinterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Wells Fargo: Consulting Fees (e.g., advisory boards) (Ongoing); WL Gore & Associates: Consulting fees or other remuneration (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)
Robert J. Widmer, MD, PhD (he/him/his)

Director Interventional Cath Labs
Baylor Scott & White Health
Belton, Texas, United States

Disclosure(s): Abbot Vascular: Consultant/Advisory Board (Ongoing), Fees for Non-CME Services Received Directly from Commercial Interest or their Agents (e.g., speakers' bureaus) (Ongoing); Philips-Spectranetics: Consultant/Advisory Board (Ongoing)

Panel Discussant(s)

Davide Capodanno, MD, PhD

Associate Professor
Division of Cardiology, CAST, "Policlinico-Vittorio Emanuele", University of Catania
Catania, Sicilia, Italy

Disclosure(s): No relevant disclosure to display
Philippe Généreux, MD

Co-Director, Valve & Structural Heart Center
Morristown Medical Center
Morristown, New Jersey, United States

Disclosure(s): Puzzle Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Shareholder (Ongoing)
Amar Krishnaswamy, MD

Program Director, Interventional Cardiology Fellowship
Cleveland Clinic
Cleveland, Ohio, United States

Disclosure(s): No financial relationships to disclose
Jeffrey A. Southard, MD, FACC, FSCAI (he/him/his)

Professor of Medicine Director -TAVR Program Medical Director- Cath Lab
UC Davis Medical Center
West Sacramento, California, United States

Disclosure(s): Boston Scientific Corporation: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consulting fees or other remuneration (Ongoing), Speakers' Bureau (Ongoing); Philips; Abbott: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing)
Nicolas M. Van Mieghem, MD, PhD, FESC, FACC

Professor and Clinical Director of Interventional cardiology
Thoraxcenter
Rotterdam, Zuid-Holland, Netherlands

Disclosure(s): Abbott Inc: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Anteris: Consultant/Advisory Board (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); BostonScientific: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo, Inc.: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); JenaValve Technology Inc: Consultant/Advisory Board (Ongoing); Medtronic Inc: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); PulseCath BV: Consultant/Advisory Board (Ongoing)
Jason Wasfy, MD

Director of Outcomes Research
Massachusetts General Hospital
Cambridge, Massachusetts, United States

Disclosure(s): Pfizer: Consultant (Terminated)

Disclosure(s):

Howard C. Herrmann, MD, FACC, MSCAI: Abbott Vascular, Edwards, Medtronic, Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Highlife Medical: Contracted Research (Ongoing); Holistick Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Innovalve: Grant/Research Support (Ongoing); medtronic: Consultant (Ongoing); Microinterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Wells Fargo: Consulting Fees (e.g., advisory boards) (Ongoing); WL Gore & Associates: Consulting fees or other remuneration (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)

Robert J. Widmer, MD, PhD: Abbot Vascular: Consultant/Advisory Board (Ongoing), Fees for Non-CME Services Received Directly from Commercial Interest or their Agents (e.g., speakers' bureaus) (Ongoing); Philips-Spectranetics: Consultant/Advisory Board (Ongoing)

Davide Capodanno, MD, PhD: No relevant disclosure to display

Hemal Gada, MD: Abbott Cardiovascular Systems: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing)

Philippe Généreux, MD: Puzzle Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Shareholder (Ongoing)

Amar Krishnaswamy, MD: No financial relationships to disclose

Raj Makkar, MD, FSCAI: Abbott: Grant/Research Support (Ongoing); Cedars-Sinai Medical Center: Employee (Ongoing); Cordis: Consultant (Ongoing); Edwards Lifesciences: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Medtronic: Consultant (Ongoing)

Jeffrey A. Southard, MD, FACC, FSCAI: Boston Scientific Corporation: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consulting fees or other remuneration (Ongoing), Speakers' Bureau (Ongoing); Philips; Abbott: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing)

Nicolas M. Van Mieghem, MD, PhD, FESC, FACC: Abbott Inc: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Anteris: Consultant/Advisory Board (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); BostonScientific: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo, Inc.: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); JenaValve Technology Inc: Consultant/Advisory Board (Ongoing); Medtronic Inc: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); PulseCath BV: Consultant/Advisory Board (Ongoing)

Jason Wasfy, MD: Pfizer: Consultant (Terminated)